InsiderClue
Insiders · Profile

Scott Kathleen D.

Director at Dermata Therapeutics · Chief Financial Officer at ARS Pharmaceuticals. Filing since 29 Nov 2022. CIK 0001794284

DRMA Dermata Therapeutics, Inc. Director · 1 trade SPRY ARS Pharmaceuticals, Inc. Chief Financial Officer · 5 trades
Company
Date
Role
Action
Shares
Amount
Of holding
DRMA Dermata Therapeutics, Inc.
16 Jun 2026
Director
Sold at will
11
$13.09
100%
SPRY ARS Pharmaceuticals, Inc.
21 Aug 2025
Chief Financial Officer
Sold on a plan
12,500
$187.50K
55.5%
SPRY ARS Pharmaceuticals, Inc.
20 May 2025
Chief Financial Officer
Sold at will
50,000
$705.17K
87.1%
SPRY ARS Pharmaceuticals, Inc.
16 Oct 2024
Chief Financial Officer
Sold on a plan
12,500
$200.00K
71.6%
SPRY ARS Pharmaceuticals, Inc.
20 Aug 2024
Chief Financial Officer
Sold on a plan
12,500
$200.00K
48.6%
SPRY ARS Pharmaceuticals, Inc.
29 Nov 2022
Chief Financial Officer
Bought
8,250
$51.51K
opened
6 decisions on file.